Literature DB >> 16182500

Predictive value of the early clinical signs in Rett disorder.

Alison M Kerr1, Robin J Prescott.   

Abstract

The British Isles Survey for Rett has registered 1,159 cases over up to 20 years. Indicators of health and severity, recorded at intervals throughout life, are drawn from clinical examinations, reports and postal questionnaires. This study aimed to establish the stability and predictive value of an early severity score based on muscle tone, locomotor ability, feeding difficulty, scoliosis and epilepsy. Data from people with clinically documented classic or non-classic Rett and health records over 20-30 years indicate that severity scores tend to increase throughout the first 15 years and then to stabilise in mild and severe, classic and non-classic Rett. Severity scores before regression reflect later severity scores within relatively wide inter-quartile ranges. In general, the adult severity level is around 40 points above the pre-regression level for classic Rett and around 20 points for non-classic Rett. High early severity scores are associated with reduced cumulative survival. Used with caution, early signs are helpful in diagnosis and prognosis. The mutations T158M, R255X and R168X are generally associated with more severe and R306C and R133C with less severe disease but exceptions make these unreliable predictors of outcome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16182500     DOI: 10.1016/j.braindev.2004.10.007

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  8 in total

1.  The association between behavior and genotype in Rett syndrome using the Australian Rett Syndrome Database.

Authors:  Laila Robertson; Sonĵa E Hall; Peter Jacoby; Carolyn Ellaway; Nick de Klerk; Helen Leonard
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-03-05       Impact factor: 3.568

2.  Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin.

Authors:  Tatiana Nikitina; Xi Shi; Rajarshi P Ghosh; Rachel A Horowitz-Scherer; Jeffrey C Hansen; Christopher L Woodcock
Journal:  Mol Cell Biol       Date:  2006-11-13       Impact factor: 4.272

3.  Gross rearrangements of the MECP2 gene are found in both classical and atypical Rett syndrome patients.

Authors:  H L Archer; S D Whatley; J C Evans; D Ravine; P Huppke; A Kerr; D Bunyan; B Kerr; E Sweeney; S J Davies; W Reardon; J Horn; K D MacDermot; R A Smith; A Magee; A Donaldson; Y Crow; G Hermon; Z Miedzybrodzka; D N Cooper; L Lazarou; R Butler; J Sampson; D T Pilz; F Laccone; A J Clarke
Journal:  J Med Genet       Date:  2005-09-23       Impact factor: 6.318

4.  InterRett, a model for international data collection in a rare genetic disorder.

Authors:  Sandra Louise; Sue Fyfe; Ami Bebbington; Nadia Bahi-Buisson; Alison Anderson; Mercé Pineda; Alan Percy; Bruria Ben Zeev; Xi Ru Wu; Xinhua Bao; Patrick Mac Leod; Judith Armstrong; Helen Leonard
Journal:  Res Autism Spectr Disord       Date:  2009-07

5.  Sleep problems in Rett syndrome.

Authors:  Deidra Young; Lakshmi Nagarajan; Nick de Klerk; Peter Jacoby; Carolyn Ellaway; Helen Leonard
Journal:  Brain Dev       Date:  2007-05-24       Impact factor: 1.961

6.  Gross motor profile in rett syndrome as determined by video analysis.

Authors:  J A Downs; A Bebbington; P Jacoby; M E Msall; O McIlroy; S Fyfe; N Bahi-Buisson; W E Kaufmann; H Leonard
Journal:  Neuropediatrics       Date:  2009-01-22       Impact factor: 1.947

7.  Neurophysiology versus clinical genetics in Rett syndrome: A multicenter study.

Authors:  Nicky Halbach; Eric E Smeets; Peter Julu; Ingegerd Witt-Engerström; Giorgio Pini; Stefania Bigoni; Stig Hansen; Flora Apartopoulos; Robert Delamont; Kees van Roozendaal; Maria F Scusa; Paolo Borelli; Math Candel; Leopold Curfs
Journal:  Am J Med Genet A       Date:  2016-06-29       Impact factor: 2.802

8.  Early development in Rett syndrome - the benefits and difficulties of a birth cohort approach.

Authors:  Peter B Marschik; Sanne Lemcke; Christa Einspieler; Dajie Zhang; Sven Bölte; Gillian S Townend; Marlene B Lauritsen
Journal:  Dev Neurorehabil       Date:  2017-05-23       Impact factor: 2.308

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.